46 Years of Experience
Affiliated with a Castle Connolly Top Hospital
Who is Dr. Steinman, Neurologist in Palo Alto, CA?
Dr. Lawrence Steinman, MD is a Neurologist, who primarily practices in Palo Alto, CA with 1 additional practice location. He has been practicing for over 46 years. Dr. Steinman completed his residency at Stanford Univ Hosp, Neurology Stanford Univ Hosp, Pediatrics. Dr. Steinman is fluent in English and Spanish, and is currently seeing new patients. Dr. Steinman’s practice accepts Kaiser Permanente and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. Steinman’s office at (650) 498-5710.
Where did Dr. Steinman go to medical school and complete their residency?
Residency: Stanford Univ Hosp, Neurology Stanford Univ Hosp, Pediatrics
Medical School: Harvard Medical School, Boston, Massachusetts
What languages does Dr. Steinman speak?
Dr. Steinman and their clinical team can communicate with patients in the following languages:
English
Spanish
What conditions does a Neurologist like Dr. Steinman typically treat?
As a Neurologist, conditions treated by Dr. Lawrence Steinman may include:
Please contact Dr. Steinman's office directly to confirm care for your specific condition, for more information, or to schedule a consultation.
What procedures does a Neurologist like Dr. Steinman typically perform?
As a Neurologist, procedures performed by Dr. Lawrence Steinman may include:
- Aging Brain (Neuropsychological Testing)
- Cortical Basal Ganglionic Degeneration (CBGD)
- Deep Brain Stimulation
- Disturbance of Skin Sensation
- Electroencephalogram (EEG)
- Evoked Potential Testing
- Gait Simulation
- Greater Occipital Nerve (GON) Block
Please contact Dr. Steinman's office directly to confirm care for your specific procedure, for more information, or to schedule a consultation.
Does Dr. Steinman accept my insurance?
Dr. Steinman accepts most major insurance plans. Important: Please call our office at (650) 498-5710 before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. Steinman accept in Palo Alto, CA?
Dr. Steinman in Palo Alto, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
California Water Service Group
Centene Corporation
CVS Health (formerly Aetna)
Federal government of the United States
Kaiser Permanente
State of California
UnitedHealth Group
Unknown
View All Insurances
Where is Dr. Steinman's office located?
Recognitions
Publications
Plasmid-Encoded Proinsulin Preserves C
, 2013
Expansion of oligodendrocyte progenitor cells following SIRT1 ictivation in the adult brain.
, 2013
Amyloid Fibrils Composed of Hexameric Peptides Attenuate Neuroinflammation
, 2013
A writing-intensive course improves biology undergraduates' perception
, 2013
Weighing in on autoimmune disease: 'Hub-and-spoke' T cell traffic in autoimmunity.
, 2013
Inflammatory Cytokines at the Summits of Pathological Sigl Cascades in Brain Diseases
, 2013
Piet Mondrian's trees and the evolution in understanding multiple sclerosis
, 2013
The discovery of talizumab, a potent therapeutic for multiple sclerosis
, 2012
Chaperone Activity of Small Heat Shock Proteins Underlies Therapeutic Efficacy
, 2012
Reversal of Paralysis and Reduced Inflammation from Peripheral Administration of beta-Amyloid in T
, 2012
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice
, 2012
Peroxisome proliferator-activated receptor
, 2012
Identification of turally Occurring Fatty Acids of the Myelin Sheath That Resolve Neuroinflammation
, 2012
Protective effect of an elastase inhibitor in a neuromyelitis optica
, 2012
Therapeutic Effects of Systemic Administration of Chaperone alpha B
, 2012
Optimization of current and future therapy for autoimmune diseases
, 2012
Systemic augmentation of alpha B-crystallin provides therapeutic benefit twelve hours post
, 2011
Functiol rescue of experimental ischemic optic neuropathy with alpha B-crystallin
, 2011
Interferon-beta exacerbates Th17-mediated inflammatory disease
, 2011
Chaperone Activity of alpha B
, 2011
Modulation of postoperative cognitive decline via blockade of inflammatory cytokines outside the
, 2010
Peroxisome proliferator
, 2010
Inverse vaccition, the opposite of Jenner's concept, for therapy of autoimmunity
, 2010
T helper type 1 and 17 cells determine efficacy of interferon
, 2010
Inhibitory role for GABA in autoimmune inflammation
, 2010
Inte and Adaptive Autoimmunity Directed to the Central Nervous System
, 2009
Blocking angiotensin-converting enzyme induces potent regulatory T cells and modulates TH1
, 2009
A molecular trio in relapse and remission in multiple sclerosis
, 2009
Improved Efficacy of a Tolerizing D Vaccine
, 2008
Nuanced roles of cytokines in three major human brain disorders
, 2008
A rush to judgment on Th17
, 2008
Phase 2 trial of a D vaccine encoding myelin basic protein for multiple sclerosis
, 2008
Proteomic alysis of active multiple sclerosis lesions reveals therapeutic targets
, 2008
Induction of antigen
, 2007
Protective and therapeutic role for alpha B-crystallin in autoimmune demyelition
, 2007
Peroxisome proliferator-activated receptor
, 2007
A brief history of T(H)17, the first major revision in the T(H)1
, 2007
Osteopontin-induced relapse
, 2007
Isoprenoids determine Th1/Th2 fate in pathogenic T cells
, 2006
Lipid microarrays identify key mediators of autoimmune brain inflammation
, 2006
Treatment of autoimmune neuroinflammation with a synthetic tryptophan metabolite
, 2005
Design of effective immunotherapy for human autoimmunity
, 2005
Blocking adhesion molecules as therapy for multiple sclerosis: talizumab
, 2005
Immune therapy for autoimmune diseases
, 2004
REVERSAL OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS WITH MONOCLOL-ANTIBODY TO A T
, 1985
DISAPPEARANCE AND REAPPEARANCE OF B-CELLS AFTER INVIVO TREATMENT WITH MONOCLOL ANTI-I-A ANTIBODIES
, 1984
INVIVO THERAPY WITH MONOCLOL ANTI-I
, 1983
Serum autoantibodies to myelin peptides distinguish acute dissemited encephalomyelitis from
, 2013
Th17 cells induce Th1-polarizing monocyte-derived dendritic cells.
, 2013
The gender gap in multiple sclerosis: intersection of science and society.
, 2013
Type I Interferons: Beneficial in Th1 and Detrimental in Th17 Autoimmunity
, 2013
A Tip leads cytotoxic T cells to the crime scene in neuroinflammation
, 2013
Transient B-Cell Depletion with Anti-CD20 in Combition with Proinsulin D Vaccine or Oral Insulin
, 2013
talizumab Bench to Bedside and Beyond
, 2013
Interleukin 17F Level and Interferon Beta Response in Patients With Multiple Sclerosis.
, 2013
The Road Not Taken: Antigen-Specific Therapy and Neuroinflammatory Disease.
, 2013
CRYAB modulates the activation of CD4+ T cells from relapsing
Serum IL-17F does not predict poor response to IM IFN beta-1a in relapsing-remitting MS
, 2012
Nostalgia: the similarities between immunological and neurological memory
, 2012
Platelets Provide a Bounty of Potential Targets for Therapy in Multiple Sclerosis
, 2012
Lessons learned at the intersection of immunology and neuroscience
, 2012
Re-engineering of Pathogenic Aquaporin 4
, 2012
The protective and therapeutic function of small heat shock proteins in neurological diseases.
, 2012
Tyrosine Kise Inhibitors Ameliorate Autoimmune Encephalomyelitis
, 2011
Interleukin-17 Accelerates Allograft Rejection by Suppressing Regulatory T Cell Expansion
, 2011
1,25-Dihydroxyvitamin D-3 Ameliorates Th17 Autoimmunity via Transcriptiol Modulation of
, 2011
Combining statins with interferon beta in multiple sclerosis
, 2011
IL-7 Promotes T(H)1 Development and Serum IL-7 Predicts Clinical Response to Interferon-beta in
, 2011
alpha B-Crystallin Improves Murine Cardiac Function
, 2011
Human peptidome display
, 2011
Vitamin D, Pregncy, Breastfeeding, and Postpartum Multiple Sclerosis Relapses
, 2011
Common variants in P2RY11 are associated with rcolepsy
, 2011
Delivery of Myelin Peptides through The First Line of Defense, Skin
, 2010
Inverse Vaccition to Silence Immunity to Myelin in Multiple Sclerosis
, 2010
Angiotensin II sustains brain inflammation in mice via TGF-beta
, 2010
alpha B-Crystallin Is a Target for Adaptive Immune Responses
, 2010
IL-17 Contributes to the Development of Chronic Rejection in a Murine Heart Transplant Model
What is Dr. Steinman's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. Steinman's National Provider Identifier (NPI) number is 1568507812.
What common questions do patients ask about Dr. Steinman?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. Steinman
What is Dr. Lawrence Steinman's specialty?
Dr. Steinman is a Neurologist near Palo Alto, CA.
What does a Neurologist do?
A neuropathologist is expert in the diagnosis of diseases of the nervous system and skeletal muscles and functions as a consultant primarily to neurologists and neurosurgeons. The neuropathologist is knowledgeable in the infirmities of humans as they affect the nervous and neuromuscular systems, be they degenerative, infectious, metabolic, immunologic, neoplastic, vascular or physical in nature.